[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Filters

Search
Categories
1,446
Publishers
457
1
1
1
98
1
2
5
3
9
2
5
1
6
7
2
1
1
2
70
21
3
2
28
1
4
1
2
2
6
10
8
1
57
9
2
1
3
1
1
4
21
3
2
11
3
1
15
18
16
4
1
2
16
6
1
2
1
5
1
19
20
19
27
19
5
324
17
11
2
4
1
7
Regions
4
2
1
7
1
1
1
1
1
1
4
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
1
5
4
2
2
2
1
1
1
1
1
1
1
2
1
1
1
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
10
30
13
1
5
4
2
2
2
2
3
2
4
25
2
17
2
5
15
13
4
36
1,157
Price
Date
Pages
Offers
98
1

Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Publications found: 1,446
Sort by:
Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026 US$ 3,000.00

... Peptide Therapeutics, Peptide Vaccine & Peptide Hormone Global Peptide Therapeutics Market Dynamics Global Peptide Clinical Pipeline by Company, Indication & Phase Global Peptide Pipeline: 722 Peptides Majority Peptides in Preclinical Phase: 308 Peptides Commercially Available Peptides: 136 Peptides ...

January 2020 1500 pages
Proton Therapy in Cancer: Global Markets US$ 4,400.00

REPORT SCOPE: BCC Research’s new report, “Proton Therapy in Cancer: Global Markets,” provides a comprehensive analysis of the proton therapy market in global context, including market forecasts and...

December 2019 185 pages
Highs and Lows of Stem Cell Therapies: Off- The-Shelf Solutions US$ 3,160.00

REPORT INCLUDES: An overview of recent advances in stem cell therapies and coverage of potential stem cells used for regenerative advanced therapiesDiscussion on role of genomic and epigenomics manip...

December 2019 25 pages
Global CAR T Cell Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026 US$ 3,950.00

Value Market Research’s latest report on the Global CAR T Cell Therapy Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the...

December 2019 100 pages
Cystic Fibrosis (CF) Therapeutics Market by Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, and CFTR Modulators) and Route of Administration (Oral and Inhaled): Global Opportunity Analysis and Industry Forecast, 2019-2026 US$ 5,370.00

The global cystic fibrosis therapeutics market was valued at $4,615.4 million in 2018 and is expected to reach $9,277.3 million by 2026, registering a CAGR of 9.2% from 2019 to 2026. Cystic fibrosis i...

November 2019 187 pages
Dermatologicals in Hong Kong, China US$ 990.00

... The humidity and high levels of air pollution seen in Hong Kong have been associated with skin problems, including inflammatory or allergic ... to have a negative impact on skin health. Euromonitor International's Dermatologicals in Hong Kong, China report offers a comprehensive guide to the size and shape of the ...

November 2019 21 pages
Allergic Rhinitis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 166 pages
Urinary Incontinence - Pipeline Review, H2 2019 US$ 2,000.00

... Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Urinary Incontinence and features dormant and discontinued projects. The guide covers therapeutics under Development ...

November 2019 72 pages
Endometriosis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Endometriosis (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Endometriosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 134 pages
Bronchitis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Bronchitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 129 pages
Cystic Fibrosis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 489 pages
Polycystic Ovarian Syndrome - Pipeline Review, H2 2019 US$ 2,000.00

... . The Polycystic Ovarian Syndrome (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Polycystic Ovarian Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 50 pages
Sinusitis - Pipeline Review, H2 2019 US$ 2,000.00

... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sinusitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 117 pages
Anal Cancer - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Anal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 475 pages
Choroidal Neovascularization - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Choroidal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Choroidal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 57 pages
Pulmonary Arterial Hypertension - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Pulmonary Arterial Hypertension (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Pulmonary Arterial Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 364 pages
Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2019 US$ 2,000.00

... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 88 pages
Acromegaly - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Acromegaly (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Acromegaly and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 102 pages
Alopecia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 184 pages
Anthrax - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 110 pages
Cough - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Cough (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 99 pages
Glomerulonephritis - Pipeline Review, H2 2019 US$ 2,000.00

... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Glomerulonephritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 281 pages
Neutropenia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Neutropenia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 131 pages
Ocular Hypertension - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Ocular Hypertension (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Ocular Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 144 pages
Fragile X Syndrome - Pipeline Review, H2 2019 US$ 2,000.00

... . The Fragile X Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fragile X Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 172 pages
Hyperuricemia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Hyperuricemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperuricemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 85 pages
Tinnitus - Pipeline Review, H2 2019 US$ 2,000.00

... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Tinnitus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 48 pages
Bacterial Conjunctivitis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Bacterial Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 31 pages
Myocardial Infarction - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Myocardial Infarction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Infarction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 332 pages
Myocardial Ischemia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Myocardial Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 87 pages
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2019 US$ 2,000.00

... (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

November 2019 280 pages
Rectal Cancer - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Rectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 186 pages
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 137 pages
Dementia - Pipeline Review, H2 2019 US$ 2,000.00

... . The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 371 pages
Insulin Resistance - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 48 pages
Thalassemia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Thalassemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thalassemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 207 pages
Leiomyosarcoma - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Leiomyosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Leiomyosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 528 pages
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The B-Cell Chronic Lymphocytic Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for B-Cell Chronic Lymphocytic Leukemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 190 pages
Retinopathy Of Prematurity - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Retinopathy Of Prematurity (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinopathy Of Prematurity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 67 pages
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2019 US$ 2,000.00

... . The Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Proliferative Diabetic Retinopathy (PDR) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 60 pages
Bone Fracture - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Bone Fracture (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Bone Fracture and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 75 pages
Batten Disease - Pipeline Review, H2 2019 US$ 2,000.00

... . The Batten Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Batten Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 87 pages
Uveitis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Uveitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Uveitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 248 pages
Axillary Hyperhidrosis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Axillary Hyperhidrosis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Axillary Hyperhidrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 47 pages
Cerebral Palsy - Pipeline Review, H2 2019 US$ 2,000.00

Cerebral Palsy - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy - Pipeline Review, H2 2017, provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape. Cerebral palsy is a group of disorders that can ...

November 2019 44 pages
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2019 US$ 2,000.00

... . The Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Paroxysmal Nocturnal Hemoglobinuria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 126 pages
Contact Dermatitis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Contact Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 37 pages
Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2019 US$ 2,000.00

... . The Leber Congenital Amaurosis (LCA) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Leber Congenital Amaurosis (LCA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

November 2019 75 pages
Myocarditis - Pipeline Review, H2 2019 US$ 2,000.00

... releases. The Myocarditis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocarditis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

November 2019 42 pages